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Abstract : The low attenuation area (LAA) of the lungs on high resolution computed 
tomography (HRCT) was evaluated in 20 asthmatics (1 0 ex- smokers and 10 never - 
smokers) and 10 patients with pulmonary emphysema (all ex-smokers) by ventilatory 
function, lung volume, DLco, and a ratio of expiratory Winspiratory LAA. 1 . The 
%LAA of the lungs on HRCT was significantly larger in patients with pulmonary em- 
physema (PE) than in those with asthma, but there was not significant difference in 
%LAA between ex-smokers and never-smokers of asthmatics . 2 . A ratio of 
expiratory Winspiratory LAA was significantly higher in patients with PE than in 
those with asthma , and the ratio was significantly higher in ex-smokers of asthmatics 
than in never-smokers (p<0.05). 3 . The difference in %residual volume and %DLco 
was significant between asthma and PE , and between ex - smokers and never - smokers 
of asthmatics (%RV : p<0.05, DLco : p<0.05) . 4 . The difference in the values of 
%FVC, %FEVl .O, and FEV1.0% was significant between asthma and PE, but not sig- 
nificant between ex- smokers and never- smokers of asthmatics. The results suggest 
that the difference in a ratio of expiratory W inspiratory LAA, %RV and %DLco was 
significant between ex - smokers and never - smokers of asthmatics , and cigarette 
smoking induces more irreversible changes of the lungs. 
Key words : low attenuation area, asthma, pulmonary emphysema, cigarette smoking, 
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Introduction 
Asthma is a disease characterized by transient 
wheezing and dyspnea elicited by narrowing of 
the airways due to bronchoconstriction, edema 
of mucous membrane, and hypersecretion. The 
main pathogenesis of onset mechanisms of the 
disease is well known to be airway inflammation, 
in which IgE-mediated allergy play an important 
role, and an increase in muscle mass, mucous 
gland hypertrophy, and reorganization of the 
extracellular matrix, have been found in the in- 
flammatory process. 
Furthermore, airway reconstruction such as 
bronchial wall thickening, bronchiectasis , em- 
physematous changes' 3 ' ,  and mosaic patterns 
of lung attenuation has been found by high 
resolution computed tomography (HRCT) in pa- 
tients with asthma4. 5'. It has been shown that 
asthmatics with abnormal HRCT findings dem- 
onstrate poorer lung function and less 
hyperresponsive bronchi than those with normal 
HRCT findings6'. 
In contrast, low attenuation area (LAA) < -950 
Hounsfield Units (HU) of the lungs on HRCT 
scans obtained at full inspiration is an objective 
measure of pulmonary emphysema7.''. A previ- 
ous study suggested that the percentage of pix- 
els below -900 HU is significantly correlated 
with pulmonary function, and reflects air trapping 
in patients with asthmag'. However, the signifi- 
cance of the %LAA of the lungs on HRCT 
scans in asthma has not been determined. 
In the present study, the significance of 
%LAA of the lungs on HRCT in asthma was ex- 
amined by comparing the %LAA of asthmatics 
with the %LAA in patients with pulmonary em- 
physema, and further by comparing the %LAA 
of never-smokers of asthmatics with the %LAA 
of ex-smokers in relation to pulmonary function. 
asthma and emphysema 
Subjects and Methods 
The subjects of this study were 20 asthmatics 
and 10 patients with pulmonary emphysema (PE) . 
Of 20 asthmatics, 10 were never-smokers (5 fe- 
males and 5 males, mean age 66.3 years), and 
the residual 10 were ex-smokers (all males, 
mean age 71.2 years with a smoking history of 
28.6 pack-years) . Ten patients with PE were all 
ex-smokers (all males, 68.8 years with a smok- 
ing history of 46. 7 pack-years) . Diagnosis of 
PE was made by clinical symptoms, pulmonary 
function, chest radiography and CT findings'''. 
All subjects had a modified HRCT scan of the 
lungs with a Toshiba Xpeed scanner (Toshiba 
Co) using the thin section (2 mm collimation) 
technique and a high-resolution reconstruction 
algorithm. An intravenous contrast medium 
was not administered. The scanning time was 
2 . 7  seconds, tube current was 200 mA, and 
voltage was 120 kVp. Maximal inspiratory and 
maximal expiratory HRCT scans were obtained 
at the following three selected anatomic levels 
as described by Miniati et a1. "' : (1) top of 
the aortic arch, (2) origin of the lower lobe 
bronchus, and (3) 3cm abovgt the top of the 
diaphragm. In this study, the relative area of 
the lungs with an attenuation value lower than 
-950 HU at the second level (origin of the 
lower lobe bronchus) was obtained both at full 
inspiration (inspiratory LAA) and full expiration 
(expiratory LAA) . The ratio of expiratory LAA 
to inspiratory LAA was also calculated. 
Spirometry was performed by means of a 
CHESTAC 33 (Chest Co) linked to a computer 
when their symptoms were stable. The following 
measurements were performed in all subjects : 
forced vital capacity (FVC) , forced expiratory 
volume in one second (FEV1.O) , and FEV1. O/ 
FVC (FEV1.0%) . Residual volume (RV) was 
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measured by body plethysmography (Autobox 
2800, Chest Co) . The di£fusing capacity for car- 
bon monoxide (DLco) was measured by the sin- 
gle breath technique using a CHESTAC 33. The 
actual DLco values were corrected for hemoglo- 
bin and carbon monoxide levels. The FVC, 
FEV1.O, RV, and DLco measurements for each 
patient were expressed as a percent of the pre- 
dicted values. 
Serum IgE was measured by radioimmuno- 
sorbent test (RIST) , and serum IgE antibodies 
specific to aeroallergens including house dust 
mite, pollens. Moulds, and animal danders 
were measured using the Pharmacia CAP sys- 
tem (Pharmacia Diagnostics SAB) . 
Statistically significant differences of the mean 
were estimated using the unpaired Student's t 
test. A p value of <0.05 was regarded as sig- 
nificant. 
Results 
The mean serum IgE level was 298 IU/ml 
(range 30-925 IU/ml) in never-smokers, 279 
IU/ml (33-839 IU/ml) in ex-smokers of asth- 
matics, and 580 IU/ml (15-2298 IU/ml) in 
patients with PE. A positive RAST score against 
inhalant allergens was observed in 3 of 10 never- 
smokers, 7 of 10 ex-smokers of asthmatics, 
and 6 of 10 patients with PE. 
The %LAA of the lungs on HRCT, ratio of 
expiratory LAA to inspiratory LAA, %FVC, 
%FEV1.0, FEV1.0%, %RV, and %DLco, 
were significantly different between asthmatics 
and patients with PE. The %LAA of the lungs 
on HRCT was significantly larger in patients 
with PE than in asthmatics, however, the d i e r -  
ence in the %LAA was not significant between 
never-smokers and ex-smokers of asthmatics 
(Fig. 1 ) . In contrast, a ratio of expiratory LAA 
to inspiratory LAA was significantly higher in 
ex-smokers than in never-smokers of asthmat- 
ics (p<O. 05) (Fig. 2 ) . 
never-smoker ex-smoker 
bronchial asthma pulmonary 
emphysema 
Fig.1. %Low attenuation area (LAA) of the lung on high-resolution 
computed tomography (HRCT) in patients with asthma and 
in those with pulmonary emphysema. a:p<O.OZ, b:p<0.001. 
never-smoker ex-smoker 
bronchial asthma pulmonary 
emphysema 
Fig.2. A ratio of LAA (expiratory/inspiratory)in patients with 
asthma and in those with pulmonary emphysema. a:p0.05, 
b:p<0.001. 
A significant difference between never-smok- 
ers and ex-smokers of asthmatics was observed 
in %RV (p<0.05) (Fig. 3 ) and %DLco (p< 
0.05) (Fig. 4 ) . However, a difference in 
%FIX, %FEVl . 0  and FEV1.0% values was 
not significant between never-smokers and ex- 
smokers in asthma (Fig. 5 ,  6 ,  7 ) .  
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Fig.3. %Residual d u m e  (%RV) in patients with asthma and in 
those with pulmonary emphysema. a:p<0.05, b:p<0.001. 
Fig.6. 46FEV1.0 in patients with asthma and in those with 
pulmonary emphysema. a:p<0.001, b:p<O.Ol . 
never-smoker ex-smoker never-srndrw ex-smoker 
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Fig.7. FEVI .O% in patients with asthma and in those with 
pulmonary emphysema. a:p<O.Ol , b:p<O.Ol . Fig.4. %DLco in patients with asthma and in those with pulmonary emphysema. a:p<0.05. b:p<0.001. 
Discussion 
Pulmonary emphysema is defined in structural 
terms as 'a condition of the lung characterized 
by abnormal, permanent enlargement of the 
airspaces distal to the terminal bronchiole, ac- 
companied by destruction of their walls'"'. Re- 
garding the evaluation of PE, it has been sug- 
gested that the diagnosis of PE by pathologic 
examination is correlated with HRCT scan find- 
ing~'~-'". 
The LAA <-950 HU of the lungs on HRCT 
scans at full inspiration is an objective measure 
never-smoker ex-smoker 
bronchial asthma pulmonary 
emphysema 
Fig.5. %FVC in patients with asthma and in those with pulmonary 
emphysema. a:p<0.001, b:p<0.01. 
39 Low attenation area in asthma and emphysema 
of the extent of PE7. '.I5'. The qualitative analy- 
sis of emphysema has been carried out accord- 
ing to a visual score introduced by Sakai, et 
a1. 16' based on the assessment of two aspects of 
emphysema : severity and extent. Severity was 
graded on a 4-point scale : 0, no emphysema ; 
1, low attenuation areas < 5 mm in diameter 
(type 1) ; 2, circumscribed low attenuation ar- 
eas > 5 mm in diameter with intervening nor- 
mal lung (type 2) ; 3, d i i s e  low attenuation 
areas without intervening normal lung (type 3) 
as shown in Fig. 8 .  The extent of emphysema 
was on a 4-point scale : 1, <25% of the lung 
involvement ; 2,25% to 50% lung involvement ; 
3, 50 to 75% lung in-volvemment ; 4, >75% 
lung involvement. 
/ 1. LAA<S mm in diameter (type 1) I 
2. Circumscribed LAA>5 mm in diameter 
with intervening normal lung (type 2) I 
3. Diffuse LAA without intervening normal 1 lung (type 3) 
Fig. 8. Severity of low attenuation area (LAA) 
< -950 HU of the lung on HRCT 
The extent of %LAA of the lungs on HRCT 
was significantly larger in patients with PE 
than in those with asthma, however, a signifi- 
cant difference in the extent of %LAA was not 
found between never- smokers and ex- smokers 
of asthmatics. Regarding the severity of emphy- 
sema, all asthmatics showed low attenuation ar- 
eas < 5 mm in diameter of the lungs (type 1) . 
In contrast, diffuse low attenuation areas with- 
out intervening normal lung (type 3) were ob- 
served in many patients with PE, and circum- 
scribed low attenuation areas < 5 mm in 
diameter with intervening normal lung (type 2) 
were in some. 
In addition to different severity of LAA be- 
tween asthmatics and patients with PE, the ratio 
of expiratory LAA to inspiratory LAA was signifi- 
cantly different between asthmatics and patients 
with PE. Furthermore, a significant difference 
in the ratio of expiratory LAA to inspiratory LAA 
was observed between never-smokers and ex- 
smokers of asthmatics : the ratio was significantly 
higher in ex-smokers than in never-smokers of 
asthmatics. The results obtained here suggest 
that cigarette smoking induces more irreversible 
changes of the lungs compared with never- 
smoking. The higher ratio of expiratory LAA 
to inspiratory LAA of the lungs was closely cor- 
related with %RV and %DLco, but not with 
%FVC. %FEV1.0 and FEV1.0%. 
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値を示したが，気管支喘息の喫煙例と非喫煙例の  
間には有意に差は見られなかった。2．呼気Ⅰ一AA  
／吸気IAA比は，喘息症例に比べ肺気腫症例で有  
意に高い値を示した。また，哨息の中では，喫煙  
例で非喫煙例に比べ有意に高い値が示された。3．  
％RVおよび％DI∫0は，肺気腫と喘息症例との間  
で，また喘息症例では，喫煙例と非喫煙例の間で  
有意の差が見られた。4．％FVC，％FEVl．0お  
よびFEVl．0％値はいずれも．肺気腫と喘息の間で  
は有意の差が見られたが，職息の喫煙例と非喫煙  
例の間には有意の差は見られなかった。以上の結  
果より，肺気腫と喘息の間では全てのパラメーター  
で有意差が，また喘息の喫煙例と非喫煙例の間で  
は，呼気1AA／吸気uA此，％RV，％DIJOで有  
意差が見られることが示唆された。   
肺気腫と喘息のHRCT上の10W attenuation are  
（UIA）の性質の差。喫煙との関連を含めて  
光延文裕，保崎泰弘，芦田耕三，岩垣尚史，  
永田拓也，藤井 誠，高田真吾，横井 正l），  
浜田全紀1），谷崎勝朗  
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気管支喘息20例（10例：喫煙例，10例非喫煙例）  
および肺気腫10例（全例喫煙例）を対象に，high  
resolution computed tomography（HRCT）上の  
肺のlow attenuation area（I」AA）の臨床的意義に  
ついて検討を加えた。1．HRCT上の肺の％IAA  
は，肺気腫において気管支喘息に比べ有意に高い  
